Experts have developed a new tool for surgical prioritization and ranking for patients with head and neck cancer in a scarce-resource settings associated with the COVID-19 pandemic.
By 2016, radical prostatectomy use nearly equaled radiation therapy use for high-risk prostate cancer.
Investigators highlight the importance of preoperative renal biopsy to rule out an indolent or benign tumor in patients with stage 4 CKD.
A study showed that mortality risk was reduced by 59% for patients who underwent complete metastasectomy compared with those who did not.
Outcomes and survival improved for early-stage oropharyngeal cancer, but not other cancers.
A retrospective review of women treated for breast cancer diagnosed in 2010-2016 demonstrated the effects of delays in time to surgery for DCIS and cT1-2N0 disease.
Patients with localized prostate cancer characterized by high-risk features are at increased risk of a negative outcome following radical prostatectomy.
The odds of developing a surgical infection after cytoreductive surgery for ovarian cancer more than doubled in women who had bowel resection or repair.
Patients with early-stage breast cancer who undergo mastectomy with or without reconstruction are at risk of prolonged opioid use.
Investigators performed a literature review to better understand how delays in treatment might affect clinical outcomes in urologic cancer patients, including the risk of upstaging, recurrence, and mortality.
